General Psychiatry - Articles - Page 39

Shining a Light on PTSD

June 29, 2021

Edmund Higgins, MD Dr. Higgins has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

This first-of-its-kind study looked at lightbox in PTSD with a randomized, placebo-controlled design.

CME Post-Test - Depression, TCPR, June/July 2021

June 29, 2021

By successfully completing the test you will be awarded a certificate for 2 CME credits.

Learning Objectives, Depression, TCPR, June/July 2021

June 29, 2021

After reading these articles, you should be able to…

In Brief: Lamotrigine Gets a New Warning

May 4, 2021

Chris Aiken, MD, and Sarah Rivelli, MD.

Chris Aiken, MD, and Sarah Rivelli, MD. Dr. Aiken and Dr. Rivelli have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

A new warning now sits beneath the list of life-threatening allergic reactions that can happen with lamotrigine. The anticonvulsant is suspected of causing cardiac arrhythmias in susceptible patients by slowing ventricular conduction and widening the QRS.

A Review of Medications for PTSD, With a Focus on Topiramate

May 4, 2021

Paul Riordan, MD.

Paul Riordan, MD. Assistant Consulting Professor of Psychiatry, Duke University. Dr. Riordan has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Topiramate is not first-line in PTSD, but it does have a role, particularly when alcohol use is part of the picture.

What’s Wrong With Generics?

May 4, 2021

Katherine Eban

Katherine Eban

Katherine Eban is an investigative journalist whose 2019 book Bottle of Lies: The Inside Story of the Generic Drug Boom uncovered problems in generic drug manufacturing. Ms. Eban has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Generic recalls are on the rise: Bupropion, methylphenidate, and metformin, to name a few. Katherine Eban explains the limits of FDA oversight, and what we can do to protect our patients when quality control cones under suspicion.

CLINICAL UPDATE

Depression, Vitamin D, and COVID-19

May 4, 2021

Paul Riordan, MD.

Paul Riordan, MD. Assistant Consulting Professor of Psychiatry, Duke University. Dr. Riordan has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Vitamin D deficiency is causing everything from depression to cancer to COVID-19, at least that’s what our patients are hearing. Paul Riordan looks at the strength of that research and clarifies when to check levels and when to supplement.

Maintenance Pharmacotherapy of Bipolar Disorder: How Long Is Long Enough?

May 4, 2021

Nicholas Rosenlicht, MD.

Nicholas Rosenlicht, MD. Dr. Rosenlicht has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Textbooks tell us that patients with bipolar I disorder need to take mood stabilizers for life. But what are the real risks of stopping these medications? A new meta-analysis provides some clarity.